Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

ITI Pharma and Healthcare Fund · Regular ✕Edelweiss Business Cycle Fund · Regular ✕

Growth of ₹10,000

Basics

ITI Pharma and Healthcare FundEdelweiss Business Cycle Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseITIEdelweiss
NAV₹18.7412₹9.2021
NAV date20 Nov 202620 Nov 2026
History5.0 years2.3 years
Expense ratio2.6%2.7%
Stars★★★★★Not rated
Growth Score68.80—

Returns

ITI Pharma and Healthcare FundEdelweiss Business Cycle Fund
1 month+11.19%+5.71%
3 months+3.97%+0.80%
6 months+11.37%+4.95%
YTD+19.43%+1.69%
1 year+15.93%+2.20%
3 years (CAGR)+17.74%—
5 years (CAGR)+13.47%—
10 years (CAGR)——
Since launch+13.30%−3.74%

Risk

ITI Pharma and Healthcare FundEdelweiss Business Cycle Fund
Volatility15.9%—
Downside volatility10.3%—
Sharpe0.71—
Sortino1.09—
Calmar1.01—
Return / risk1.12—
Deepest fall−18.53%−26.91%
Days to recover384—
Below its high+0.00%−10.68%

Against benchmark

ITI Pharma and Healthcare FundEdelweiss Business Cycle Fund
Alpha−3.15%—
Beta0.98—
R²84.6%—
Up capture90.7%—
Down capture104.0%—
Tracking error6.2%—
Information ratio−0.56—
Treynor0.10—

Consistency

ITI Pharma and Healthcare FundEdelweiss Business Cycle Fund
Best 1-year+58.89%+19.06%
Middle 1-year+13.39%−0.57%
Worst 1-year−11.02%−16.02%
1-year periods with a loss25.6%51.7%
Middle 3-year+19.00%—
Positive months69.4%—
Best day+3.48%+4.77%
Worst day−3.29%−3.86%
Worst 5% day−1.48%−2.02%
Positive days55.6%53.1%
NAVs a year247247

SIP of ₹10,000 a month

ITI Pharma and Healthcare FundEdelweiss Business Cycle Fund
5-year XIRR——
5-year value——
3-year XIRR+13.53%—
1-year XIRR+25.62%+7.48%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth